CPRX

Catalyst Pharmaceuticals, Inc. is a leading commercial-stage biopharmaceutical company based in Coral Gables, Florida, dedicated to the development and commercialization of novel therapies for rare neuromuscular and chronic neurological disorders. By focusing on high-impact treatments that address significant unmet medical needs, Catalyst aims to enhance the quality of life for patients afflicted by these often-overlooked conditions. The company's innovative approach and robust product pipeline position it favorably within the healthcare sector, making it a compelling investment opportunity for institutional investors interested in transformative advancements in rare disease therapeutics.